Back
ClearOne, Inc. 10K Form
Sell
35
CLRO
ClearOne, Inc.
Last Price:
$5.28
Seasonality Move:
18.25%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-17 | 10Q | CLRO/ClearOne, Inc. Quarterly |
| 2023-11-08 | 10Q | CLRO/ClearOne, Inc. Quarterly |
| 2023-08-10 | 10Q | CLRO/ClearOne, Inc. Quarterly |
| 2023-05-15 | 10Q | CLRO/ClearOne, Inc. Quarterly |
| 2022-11-14 | 10Q | CLRO/ClearOne, Inc. Quarterly |
| 2022-08-12 | 10Q | CLRO/ClearOne, Inc. Quarterly |
Receive CLRO News And Ratings
See the #1 stock for the next 7 days that we like better than CLRO
CLRO Financial Statistics
Sales & Book Value
| Annual Sales: | $11.4M |
|---|---|
| Cash Flow: | $-2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.25 |
| Price / Book: | 21.21 |
Profitability
| EPS (TTM): | -12.04990 |
|---|---|
| Net Income (TTM): | $-10.5M |
| Gross Margin: | $2.6M |
| Return on Equity: | -62.75% |
| Return on Assets: | -46.34% |
ClearOne, Inc. Earnings Forecast
Key ClearOne, Inc. Financial Ratios
-
The Gross Profit Margin over the past 38 years for CLRO is 23.09%.
-
The Selling, General & Administrative Expenses for CLRO have been equal to 75.01% of Gross Profit Margin.
-
The Research & Development expenses have been 28.97% of Revenue.
-
The Net Earning history of CLRO is -78.90% of Total Revenues.
-
Per Share Earnings over the last 38 years have been positive in 23 years.
ClearOne, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Communications Equipment |
| Sector: | Information Technology |
| Current Symbol: | CLRO |
| CUSIP: | 18506U |
| Website: | clearone.com |
Debt
| Debt-to-Equity Ratio: | 0.13 |
|---|---|
| Current Ratio: | 2.29 |
| Quick Ratio: | 0.2 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CLRO Technical Analysis vs Fundamental Analysis
Sell
35
ClearOne, Inc. (CLRO)
is a Sell
Is ClearOne, Inc. a Buy or a Sell?
-
ClearOne, Inc. stock is rated a SellThe current ClearOne, Inc. [CLRO] share price is $5.33. The Score for CLRO is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.